The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma

Experimental and Therapeutic Medicine

Volumn 5, Issue 3, 2013, Pages 890-896

  Lu, Hongsheng ^a   Yang, Zhaohui ^a   Zhang, Hui ^a   Gan, Meifu ^b   Zhou, Tao ^b   Wang, Siling ^a  

^a Central Hospital of Taizhou   (China)

^b TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Clear cell renal cell carcinoma; Matrix metalloproteinase 7; Prognosis; Tissue inhibitor of matrix metalloproteinases 2; Tissue microarray

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TISSUE MICROARRAY; UPREGULATION;

EID: 84873135108     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.859     Document Type: Article

References (26)

1. Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, MikamiY, Manabe T, Kamoto T, Habuchi T and Ogawa O: Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett 241: 59-63, 2006.
2. Nagase H and Woessner JF: Matrix metalloproteinases. J Biol Chem 274: 21491-21494,1999.
3. Declerck YA, Mercurio AM, Stack MS, Chapman HA, ZutterMM and Muschel RJ: Proteases, extracellular matrix and cancer: a workshop of the path B study section. Am J Pathol 164: 1131-1139, 2004.
4. Di Nezza LA, Misajon A and Zhang J: Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94: 1466-1475, 2002.
5. Egelblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
6. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD and Mansel RE: Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17: 583-590, 2006.
7. Ogata Y, Miura K, Ohkita A, Nagase H and Shirouzu K: Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma. Kurume Med J 48: 211-218, 2001.
8. Moore CS and Crocker SJ: An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 180: 12-16, 2012.
9. Hahne JC, Fuchs T, El Mustapha H, Okuducu AF, Bories JC and Wernert N: Expression pattern of matrix metalloproteinase and TIMP genes in fibroblasts derived from Ets-1 knock-out mice compared to wild-type mouse fibroblasts. Int J Mol Med 18: 153-159, 2006.
10. Abdel-Wahed MM, Asaad NY and Aleskandarany M: Expression of matrix metalloproteinase-2 in renal cell carcinoma. J Egypt Natl Canc Inst 16: 168-177, 2004.
11. Aoyama T, Yamamoto S, Kanematsu A, Ogawa O and TabataY: Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozocin-induced diabetic mice. Tissue Eng 9: 1289-1296, 2003.
12. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y and Hinoda Y: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 106: 372-374, 2003.
13. Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, MatsuyamaH, Suehiro Y, Hamanaka Y and Hinoda Y: Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Carcinogenesis 25: 2379-2384, 2004.
14. Huo N, IchikawaY and Kamiyama M: MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 177: 95-100, 2002.
15. Miyata Y, Iwata T, Maruta S, Kanda S, Nishikido M, Koga S and Kanetake H: Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role. Eur Urol 52: 791-597, 2007.
16. Struckmann K, Mertz KD, Steu S, Storz M, Staller P, Krek W, Schraml P and Moch H: pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma. J Pathol 214: 464-471, 2008.
17. Yang SD, Sun RC, Mu HJ, Xu ZQ and Zhou ZY: The expression and clinical significance of TGF-β1 and MMP2 in human renal clear cell carcinoma. Int J Surg Pathol 18: 85-93, 2010.
18. Eble JN, Sauter G, Epstein JI, and Sesterhenn IA (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. IARC Press. Lyon, France, pp16-18, 2004.
19. Lu H, Gan M, Zhang G, Zhou T, Yan M, Wang S: Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis. Eur J Gynaecol Oncol 6: 662-666, 2010.
20. Johansson N, Ahonen M and Kahari VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57: 5-15, 2000.
21. Stetler-Stevenson WG, Liotta LA and Kleiner DE: Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. Faseb J 7: 1434-1441, 1993.
22. Stetler-Stevenson WG and Yu AE: Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 11: 143-152, 2001.
23. Kawata N, Nagane Y, Hirakata H, Ichinose T, Okada Y, Yamaguchi K and Takahashi S: Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma. Urology 69: 1050-1053, 2007.
24. Kawata N, Nagane Y and Igarashi T: Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma. Urology 68: 523-527, 2006.
25. Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M and KanetakeH: Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 12: 6998-7003, 2006.
26. Kumaki F, Matsui K and Kawai T: Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia. Am J Pathol 159: 2125-2135, 2001.